Actively Recruiting
A Long-Term Follow-Up Study of Participants Exposed to REACT
Led by Prokidney · Updated on 2025-05-28
80
Participants Needed
1
Research Sites
220 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The purpose of this study is to evaluate the long-term safety of up to two gelatin-hydrogel formulation REACT injections given 3 to 6 months apart and delivered percutaneously into same kidney on renal function in participants with chronic kidney disease (CKD).
CONDITIONS
Official Title
A Long-Term Follow-Up Study of Participants Exposed to REACT
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Participants must have received gelatin-hydrogel formulation REACT in a previous trial (RMCL-002, REGEN-003, REGEN-004) for chronic kidney disease treatment and completed their parent trial's end of study visit per protocol.
You will not qualify if you...
- Participants who did not receive REACT in a previous trial for chronic kidney disease treatment.
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Boise Kidney & Hypertension Institute
Meridian, Idaho, United States, 83642
Actively Recruiting
Research Team
B
Beth Hilburger
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here